The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review

J Bondeson1, S Wainwright, C Hughes

  • 1Department of Rheumatology, Cardiff University, Cardiff School of Biosciences, Cardiff University, Cardiff, UK.

Insights

Osteoarthritis involves cartilage destruction, primarily driven by aggrecan degradation mediated by ADAMTS4 and ADAMTS5 enzymes. Proinflammatory cytokines and NF-kappaB signaling regulate these key osteoarthritis enzymes.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Rheumatology

Background:

  • Articular cartilage destruction is a hallmark of osteoarthritis.
  • Aggrecan degradation, mediated by matrix proteinases like ADAMTS enzymes, precedes irreversible collagen damage.

Purpose of the Study:

  • To review recent data on the regulation of ADAMTS4 and ADAMTS5 gene expression in osteoarthritis.
  • To emphasize the role of proinflammatory cytokines and NF-kappaB in osteoarthritis pathogenesis.

Main Methods:

  • Literature review focusing on gene expression regulation.
  • Analysis of data concerning proinflammatory cytokines and transcription factors.

Main Results:

  • ADAMTS4 and ADAMTS5 are key aggrecanases implicated in osteoarthritis.
  • Proinflammatory cytokines significantly drive the expression of these enzymes.
  • NF-kappaB acts as a crucial mediator in the expression of ADAMTS4 and ADAMTS5.

Conclusions:

  • Understanding the regulation of ADAMTS4 and ADAMTS5 is critical for osteoarthritis therapeutic development.
  • NF-kappaB and cytokine signaling represent important targets for managing osteoarthritis progression.

Related Concept Videos